{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:04:54Z","timestamp":1781625894848,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CP20\/00146"],"award-info":[{"award-number":["CP20\/00146"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["IN607D-2022-07"],"award-info":[{"award-number":["IN607D-2022-07"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["FDT201805005390"],"award-info":[{"award-number":["FDT201805005390"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["EQU201903007844"],"award-info":[{"award-number":["EQU201903007844"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-19-CE16\\u20130020"],"award-info":[{"award-number":["ANR-19-CE16\\u20130020"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-19-16\\u20130020CE"],"award-info":[{"award-number":["ANR-19-16\\u20130020CE"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-JPW2\\u20130003-03"],"award-info":[{"award-number":["ANR-20-JPW2\\u20130003-03"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019125","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012514","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red-Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01216"],"award-info":[{"award-number":["PI21\/01216"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/00916"],"award-info":[{"award-number":["PI24\/00916"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010137","name":"Fondation Sanofi Espoir","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.nbd.2025.106840","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T02:33:13Z","timestamp":1739759593000},"page":"106840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["PYK2 in the dorsal striatum of Huntington's disease R6\/2 mouse model"],"prefix":"10.1016","volume":"207","author":[{"given":"Omar","family":"Al Massadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lody","family":"Labarch\u00e8de","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"de Pins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Longueville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theano","family":"Irinopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mythili","family":"Savariradjane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enejda","family":"Subashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gin\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Caboche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise-Laure","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Betuing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Antoine","family":"Girault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106840_bb0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1523\/JNEUROSCI.4992-08.2010","article-title":"Postsynaptic clustering and activation of Pyk2 by PSD-95","volume":"30","author":"Bartos","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106840_bb0010","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves Cortico-basal ganglia function in Huntington\u2019s disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106840_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004606","article-title":"Genome-wide association meta-analysis of neuropathologic features of Alzheimer\u2019s disease and related dementias","volume":"10","author":"Beecham","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2025.106840_bb0020","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106840_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-022-00526-y","article-title":"Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy","volume":"17","author":"Brody","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.106840_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/7854_2013_256","article-title":"Mouse models of Huntington\u2019s disease","volume":"22","author":"Brooks","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2025.106840_bb0035","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s disease collaborative research group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.106840_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-020-0878-0","article-title":"Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington\u2019s disease","volume":"8","author":"Crevier-Sorbo","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.106840_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington\u2019s disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106840_bb0050","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41598-020-63426-5","article-title":"The non-receptor tyrosine kinase Pyk2 modulates acute locomotor effects of cocaine in D1 receptor-expressing neurons of the nucleus accumbens","volume":"10","author":"de Pins","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.106840_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.749001","article-title":"The non-receptor tyrosine kinase Pyk2 in brain function and neurological and psychiatric diseases","volume":"13","author":"de Pins","year":"2021","journal-title":"Front. Synaptic. Neurosci."},{"key":"10.1016\/j.nbd.2025.106840_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-240017","article-title":"Huntington\u2019s disease clinical trials corner: march 2024","volume":"13","author":"Estevez-Fraga","year":"2024","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.nbd.2025.106840_bb0065","first-page":"19","article-title":"Role of cerebral cortex in the neuropathology of Huntington\u2019s disease","volume":"7","author":"Estrada-Sanchez","year":"2013","journal-title":"Front. Neural. Circ."},{"key":"10.1016\/j.nbd.2025.106840_bb0070","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","article-title":"Prevalence of adult Huntington\u2019s disease in the UK based on diagnoses recorded in general practice records","volume":"84","author":"Evans","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2025.106840_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-7825-0_6","article-title":"Mouse models of Huntington\u2019s disease","volume":"1780","author":"Farshim","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.nbd.2025.106840_bb0080","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1172\/JCI138532","article-title":"Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating","volume":"130","author":"Favier","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.106840_bb0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12035-012-8315-4","article-title":"Mouse models of polyglutamine diseases: review and data table","volume":"46","author":"Figiel","year":"2012","journal-title":"Part I. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2025.106840_bb0090","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1471-4159.2001.00252.x","article-title":"Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression","volume":"77","author":"Freeman","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106840_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0169-328X(02)00197-3","article-title":"Changes in rat frontal cortex gene expression following chronic cocaine","volume":"104","author":"Freeman","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2025.106840_bb0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.nbd.2018.08.024","article-title":"Pharmacogenetic modulation of STEP improves motor and cognitive function in a mouse model of Huntington\u2019s disease","volume":"120","author":"Garcia-Forn","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106840_bb0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","article-title":"The R6 lines of transgenic mice: a model for screening new therapies for Huntington\u2019s disease","volume":"59","author":"Gil","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.nbd.2025.106840_bb0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tcb.2023.07.006","article-title":"PYK2, a hub of signaling circuits in breast cancer progression","volume":"34","author":"Gil-Henn","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.nbd.2025.106840_bb0115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/glia.22952","article-title":"Pyk2 is essential for astrocytes mobility following brain lesion","volume":"64","author":"Giralt","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2025.106840_bb0120","doi-asserted-by":"crossref","first-page":"15592","DOI":"10.1038\/ncomms15592","article-title":"Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington\u2019s disease model","volume":"8","author":"Giralt","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106840_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2018.05.020","article-title":"PTK2B\/Pyk2 overexpression improves a mouse model of Alzheimer\u2019s disease","volume":"307","author":"Giralt","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106840_bb0130","first-page":"1787","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","volume":"21","author":"Guyenet","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2025.106840_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.06.005","article-title":"Rodent genetic models of Huntington disease","volume":"32","author":"Heng","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106840_bb0140","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106840_bb0145","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0008-14.2015","article-title":"Enhanced GABAergic inputs contribute to functional alterations of cholinergic interneurons in the R6\/2 mouse model of Huntington\u2019s disease","volume":"2","author":"Holley","year":"2015","journal-title":"eNeuro"},{"key":"10.1016\/j.nbd.2025.106840_bb0150","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0896-6273(01)00220-3","article-title":"CAKbeta\/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus","volume":"29","author":"Huang","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106840_bb0155","doi-asserted-by":"crossref","first-page":"1020104","DOI":"10.3389\/fnmol.2022.1020104","article-title":"Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity","volume":"15","author":"Incebacak Eltemur","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2025.106840_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144898","article-title":"Polygenic analysis of late-onset Alzheimer\u2019s disease from mainland China","volume":"10","author":"Jiao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106840_bb0165","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awz174","article-title":"CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease","volume":"142","author":"Kacher","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106840_bb0170","first-page":"1","article-title":"Pyk2 overexpression in postsynaptic neurons blocks amyloid beta1\u201342-induced synaptotoxicity in microfluidic co-cultures","volume":"1","author":"Kilinc","year":"2020","journal-title":"Brain Communic."},{"key":"10.1016\/j.nbd.2025.106840_bb0175","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2025.106840_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107580","article-title":"VMAT2 inhibitors for the treatment of hyperkinetic movement disorders","volume":"212","author":"Koch","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2025.106840_bb0185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jconrel.2022.09.048","article-title":"Efficacy of gene delivery to the brain using AAV and ultrasound depends on serotypes and brain areas","volume":"351","author":"Kofoed","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.nbd.2025.106840_bb0190","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.106840_bb0195","doi-asserted-by":"crossref","first-page":"299 e13","DOI":"10.1016\/j.neurobiolaging.2020.11.009","article-title":"Genetic variants in glutamate-, Abeta-, and tau-related pathways determine polygenic risk for Alzheimer\u2019s disease","volume":"101","author":"Lawingco","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.106840_bb0200","first-page":"1615","article-title":"Neuronal density and proportion of interneurons in the associative, sensorimotor and limbic human striatum","volume":"223","author":"Lecumberri","year":"2018","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.nbd.2025.106840_bb0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington\u2019s disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2025.106840_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cells11050842","article-title":"Pyk2 regulates MAMs and mitochondrial dynamics in hippocampal neurons","volume":"11","author":"Lopez-Molina","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.106840_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106487","article-title":"Hippocampal Pyk2 regulates specific social skills: implications for schizophrenia","volume":"194","author":"Lopez-Molina","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106840_bb0220","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.106840_bb0225","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0b013e3181b04aa2","article-title":"Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants","volume":"73","author":"Marder","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106840_bb0230","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2016.2215","article-title":"Expanding the Spectrum of genes involved in Huntington disease using a combined clinical and genetic approach","volume":"73","author":"Mariani","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.106840_bb0235","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41419-020-02775-5","article-title":"Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease","volume":"11","author":"Martin-Flores","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.106840_bb0240","doi-asserted-by":"crossref","first-page":"9745","DOI":"10.1074\/jbc.M513516200","article-title":"Calpain is required for normal osteoclast function and is down-regulated by calcitonin","volume":"281","author":"Marzia","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.106840_bb0245","doi-asserted-by":"crossref","first-page":"16357","DOI":"10.1038\/s41598-021-95813-x","article-title":"Pyk2 in dorsal hippocampus plays a selective role in spatial memory and synaptic plasticity","volume":"11","author":"Mastrolia","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.106840_bb0250","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41588-024-01653-6","article-title":"Cell-type-specific CAG repeat expansions and toxicity of mutant huntingtin in human striatum and cerebellum","volume":"56","author":"Matlik","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.106840_bb0255","doi-asserted-by":"crossref","first-page":"fcac305","DOI":"10.1093\/braincomms\/fcac305","article-title":"Phosphoproteomic dysregulation in Huntington's disease mice is rescued by environmental enrichment","volume":"4","author":"Mees","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2025.106840_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106840_bb0265","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1046\/j.1460-9568.1999.00798.x","article-title":"FAK+ and PYK2\/CAKbeta, two related tyrosine kinases highly expressed in the central nervous system: similarities and differences in the expression pattern","volume":"11","author":"Menegon","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106840_bb0270","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","article-title":"Early alterations of brain cellular energy homeostasis in Huntington disease models","volume":"287","author":"Mochel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.106840_bb0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41398-018-0352-y","article-title":"Pyk2 in the amygdala modulates chronic stress sequelae via PSD-95-related micro-structural changes","volume":"9","author":"Montalban","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2025.106840_bb0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11357-016-9885-2","article-title":"Gene-based aggregate SNP associations between candidate AD genes and cognitive decline","volume":"38","author":"Nettiksimmons","year":"2016","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.nbd.2025.106840_bb0285","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41467-023-36556-3","article-title":"Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington\u2019s disease model mice","volume":"14","author":"Pancani","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106840_bb0290","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","article-title":"Dopaminergic and glutamatergic signaling crosstalk in Huntington\u2019s disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5","volume":"28","author":"Paoletti","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106840_bb0295","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington\u2019s disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.106840_bb0300","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106840_bb0305","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1523\/JNEUROSCI.1873-18.2018","article-title":"Alzheimer\u2019s disease risk factor Pyk2 mediates amyloid-beta-induced synaptic dysfunction and loss","volume":"39","author":"Salazar","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106840_bb0310","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106840_bb0315","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","article-title":"Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes","volume":"53","author":"Schwartzentruber","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.106840_bb0320","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0006-3223(02)01815-2","article-title":"Antidepressant effect of the calcium-activated tyrosine kinase Pyk2 in the lateral septum","volume":"54","author":"Sheehan","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2025.106840_bb0325","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-319-71779-1_2","article-title":"Genetic rodent models of Huntington disease","volume":"1049","author":"Stricker-Shaver","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2025.106840_bb0330","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12035-012-8316-3","article-title":"Mouse models of polyglutamine diseases in therapeutic approaches: review and data table","volume":"46","author":"Switonski","year":"2012","journal-title":"Part II. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2025.106840_bb0335","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnana.2010.00150","article-title":"Heterogeneity and diversity of striatal GABAergic interneurons","volume":"4","author":"Tepper","year":"2010","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2025.106840_bb0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2018.00091","article-title":"Heterogeneity and diversity of striatal GABAergic interneurons: update 2018","volume":"12","author":"Tepper","year":"2018","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2025.106840_bb0345","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106840_bb0350","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3233\/JAD-142442","article-title":"Genetic determinants of survival in patients with Alzheimer\u2019s disease","volume":"45","author":"Wang","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2025.106840_bb0355","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1523\/JNEUROSCI.0781-20.2021","article-title":"Cell adhesion factors in the orbitofrontal cortex control cue-induced reinstatement of cocaine seeking and amygdala-dependent goal seeking","volume":"41","author":"Whyte","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106840_bb0360","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/neu.10150","article-title":"Cholinergic interneuron characteristics and nicotinic properties in the striatum","volume":"53","author":"Zhou","year":"2002","journal-title":"J. Neurobiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:48:47Z","timestamp":1766083727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":72,"alternative-id":["S0969996125000567"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106840","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.18.576195","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PYK2 in the dorsal striatum of Huntington's disease R6\/2 mouse model","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106840"}}